Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼ºÀÎ Ä¡Á¶°ñ ³» °á¼ÕºÎ¿¡¼­ Silicon contained Coralline Hydroxyapatite¿Í Beta Tricalcium Phosphate ÇÕ¼ºÁ¦ÀçÀÇ È¿°ú¿¡ ´ëÇÑ ÀÓ»óÀû °íÂû

Effect of Silicon contained Coralline Hydroxyapatite and Beta Tricalcium Phosphate in human intrabony defects

´ëÇÑÄ¡°úÀÇ»çÇùȸÁö 2009³â 47±Ç 9È£ p.596 ~ 606
Àå¿ëÁÖ, ±è¿ëÅÂ, ¹ÚÁ¤Ã¶, ±è⼺, ÃÖ¼ºÈ£, ±èÁ¾°ü,
¼Ò¼Ó »ó¼¼Á¤º¸
Àå¿ëÁÖ ( Jang Yong-Ju ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
±è¿ëÅ ( Kim Yong-Tae ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
¹ÚÁ¤Ã¶ ( Park Jung-Chul ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
±è⼺ ( Kim Chang-Sung ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
ÃÖ¼ºÈ£ ( Choi Seong-Ho ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
±èÁ¾°ü ( Kim Chong-Kwan ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç

Abstract

Ä¡ÁÖ ÁúȯÀ¸·Î ÀÎÇÏ¿© »ó½ÇµÈ Á¶Á÷ÀÇ ¿ÏÀüÇÑ Àç»ýÀº Ä¡ÁÖ Ä¡·áÀÇ ±Ã±ØÀûÀÎ ¸ñÇ¥ÀÌ´Ù. ÇöÀç±îÁö ´Ù¾çÇÑ ¼ú½ÄÀÌ Ä¡ÁÖ ÁúȯÀÇ Ä¡·á¸¦ À§ÇÏ¿© ¼Ò°³µÇ¾î ¿ÔÀ¸³ª, ÀüÅëÀûÀÎ ¿Ü°úÀû ¹× ºñ¿Ü°úÀû Ä¡·á ½Ã ÀÓ»óÀûÀ¸·Î´Â ÀÓ»óÁöÇ¥ÀÇ °³¼±À» º¸ÀÌÁö¸¸, Á¶Á÷ÇÐÀûÀ¸·Î ±ä Á¢ÇÕ »óÇÇ ÇüÅÂÀÇ Ä¡À¯¸¦ º¸¿©¿Ô´Ù1). À̸¦ ±Øº¹ÇÏ°í Ä¡ÁÖ Á¶Á÷ÀÇ Àç»ýÀ» ´Þ¼ºÇϱâ À§ÇÑ ¹æ¹ýµéÀÌ °è¼Ó ¼Ò°³ µÇ¾ú´Âµ¥, ±× Áß °ñ À̽ļú µµ ±×Áß ÇϳªÀÌ´Ù2,3).
°ñ À̽ļúÀ» ÅëÇÑ °ñ Àç»ýÀÇ ±âÀüÀº Å©°Ô 3°¡Áö·Î ³ªÅ¸³ª´Âµ¥, °ñÀ̽ÄÀç ÀÚü¿¡ °ñ Çü¼º¼¼Æ÷¸¦ °®Ãß°í ÀÖ´Â °ñÇü¼º(Osteogenesis), °ñÀ̽ÄÀç°¡ ÁÖº¯ °ñ¸ð¼¼Æ÷µéÀÇ À¯ÀÔÀ» À§ÇÑ Àΰø ÁöÁöü·Î½á ¿ªÇÒÀ» ÇÏ´Â °ñÀüµµ(Osteoconduction) ȤÀº °ñ À¯µµ¹°ÁúÀ» Æ÷ÇÔÇÏ´Â ±âÁú·Î¼­ °ñÀ̽ÄÀç°¡ ±â´ÉÇϴ°ñÀ¯µµ(Osteoinduction)·Î ºÐ·ùÇÒ¼öÀÖ´Ù4). ÀÌ»óÀûÀÎ °ñÀÌ½Ä Àç·á´Â À§ÀÇ 3°¡Áö Á¶°ÇÀ» ¸ðµÎ °¡Áö´Â °ÍÀÌÁö¸¸, Çö½ÇÀûÀ¸·Î´Â °ñ°ú ¹é¾ÇÁú Çü¼º À¯µµ¿¡ ¿ì¼öÇÑ ´É·ÂÀ» º¸¿©¾ß ÇÏ°í, ÃÖ¼ÒÇÑÀÇ ¿°Áõ ¹ÝÀÀ°ú, ºü¸£°Ô Ç÷°üÈ­Çü¼º, ¼ö¿©ºÎ Á¶Á÷¿¡ ģȭ¼ºÀ» °¡Áö¸é¼­ Àû¿ëÇϱ⠿ëÀÌÇÏ°í, °æÁ¦ÀûÀ̾î¾ß ÇÑ´Ù5).
´ëÇ¥ÀûÀÎ °ñ ÀÌ½Ä ¹æ¹ýÀ¸·Î´Â ÀÚ°¡°ñ À̽Ä, µ¿Á¾°ñÀ̽Ä, ÀÌÁ¾°ñ À̽Ä, ÇÕ¼º°ñ ÀÌ½Ä µîÀÌ ÀÖ´Ù. ±¸°­ ³»¿Í ±¸°­ ¿Ü¿¡¼­ ¾ò¾îÁø ÀÚ°¡°ñÀº ¸é¿ª ¹ÝÀÀÀÌ ¾ø°í, ¿ùµîÇÑ °ñ Çü¼º ´É·ÂÀ» °¡Áö´Â Ç¥ÁØ °ñ À̽ÄÀç·Î¼­ Àç»ý Ä¡·á¿¡ »ç¿ëµÇ¾î ¿Ô´Ù6). ÇÏÁö¸¸ ±¤¹üÀ§ÇÏ°í ºÎ°¡ÀûÀÎ ¼ö¼ú ¿µ¿ªÀ» ÇÊ¿ä·Î Çϸç, ±× ¾çÀÌ Á¦ÇÑÀûÀÌ°í, Èí¼öÀÇ ¼Óµµ°¡ ºü¸£´Ù´Â ´ÜÁ¡ÀÌ ÀÖ´Ù. ´õºÒ¾î Ä¡±Ù À¯Âø ¹× Ä¡±Ù Èí¼öÀÇ ¹®Á¦°¡ µ¿¹° ½ÇÇè ¹× ÀÓ»ó ½ÇÇèÀ» ÅëÇÏ¿© Á¦½ÃµÇ¾î7~9) ÀÌ¿¡ º¸´Ù ÀûÇÕÇÑ °ñ À̽ÄÀçÀÇ °³¹ßÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú´Ù.

Aim£ºThe ultimate goal of periodontal treatment is regeneration of periodontium that have been lost due to inflammatory periodontal disease. Recently, Silicon contained Coralline Hydroxyapatite and Beta Tricalcium Phosphate bone substitute have been introduced to achieve periodontal regeneration. The purpose of this study is to evaluate the effect of the Silicon contained Coralline Hydroxyapatite and Beta Tricalcium Phosphate(BoneMedik-DM??, Meta Biomed Co., Ltd. Oksan, Korea) on periodontal intrabony defects.

Methods and materials£º Clinical effects of Silicon contained Coralline Hydroxyapatite and Beta Tricalcium Phosphate implantation in intrabony defects were evaluated 6 months after surgery in Sixty-one intrabony defects from Fourty-six patients with chronic periodontitis. Twenty-nine experimental defects in twenty-five patients received the Silicon contained Coralline Hydroxyapatite and Beta Tricalcium Phosphate(test group), while Thirty-Three defects in twenty-one patients were treated with flap procedure only(control group). Comparative observation were done for preoperative and postoperative differences between control and experimental clinical parameters,-clinical attachment loss(CAL), probing depth(PD), bone probing depth(BPD), gingival recession.

Results£º Postoperative improvements in CAL, PD, BPD were observed in both test and control groups(P<0.01). However, the improvements in CAL, PD, BPD of the test group were significantly greater than control group.

Conclusion£º Healing of the both groups were uneventful during experimental periods. Use of Silicon contained Coralline Hydroxyapatite and Beta Tricalcium Phosphate in a flap operation resulted in significantly greater improvements in CAL, PD, and BPD over flap operation alone. Silicon contained Coralline Hydroxyapatite and Beta Tricalcium Phosphate will be good bone substitute materials for treatment of intrabony defects.

Å°¿öµå

Silicon contained Coralline Hydroxyapatite and Beta Tricalcium Phosphate;intrabony defects;bone probing depth;probing depth;clinical attachment loss

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI